Literature DB >> 7191995

The effect of ionic strength on DNA-ligand unwinding angles for acridine and quinoline derivatives.

R L Jones, A C Lanier, R A Keel, W D Wilson.   

Abstract

We have quantitatively examined the unwinding angles for the complexes of a related series of acridine and quinoline derivatives with DNA. Ethidium bromide was used as a control for determining superhelix densities at different ionic strengths. Relative to ethidium, 9-aminoacridine and quinacrine had an essentially constant unwinding angle of approximately 17 degrees at all ionic strengths tested. The apparent unwinding angle for chloroquine and 9-amino-1,2,3,4-tetrahydroacridine was found to be ionic strength dependent, increasing with increasing ionic strength. This suggests that competitive nonintercalative binding at low ionic strengths causes an apparent lowering of the quinoline unwinding angle. This can also explain why 4-aminoquinaldine, examined at low ionic strength, gives a quite low apparent unwinding angle. Quinacrine along with chloroquinine and 9-aminoacridine approaches a limiting value for their unwinding angle of approximately 17 degrees. 4-aminoquinaldine and 9-amino-1,2,3,4-tetrahydroacridine could not be examined at an ionic strength above 0.03 because of their very low equilibrium binding constants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7191995      PMCID: PMC324020          DOI: 10.1093/nar/8.7.1613

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  16 in total

1.  The sense of naturally occurring superhelices and the unwinding angle of intercalated ethidium.

Authors:  D E Pulleyblank; A R Morgan
Journal:  J Mol Biol       Date:  1975-01-05       Impact factor: 5.469

2.  Detection of two restriction endonuclease activities in Haemophilus parainfluenzae using analytical agarose--ethidium bromide electrophoresis.

Authors:  P A Sharp; B Sugden; J Sambrook
Journal:  Biochemistry       Date:  1973-07-31       Impact factor: 3.162

3.  Interaction of closed circular DNA with intercalative dyes. II. The free energy of superhelix formation in SV40 DNA.

Authors:  W Bauer; J Vinograd
Journal:  J Mol Biol       Date:  1970-02-14       Impact factor: 5.469

4.  The degree of unwinding of the DNA helix by ethidium. I. Titration of twisted PM2 DNA molecules in alkaline cesium chloride density gradients.

Authors:  J C Wang
Journal:  J Mol Biol       Date:  1974-11-15       Impact factor: 5.469

5.  The unwinding of circular deoxyribonucleic acid by phenanthridinium drugs: structure-activity relations for the intercalation reaction.

Authors:  L P Wakelin; M J Waring
Journal:  Mol Pharmacol       Date:  1974-05       Impact factor: 4.436

6.  A non-intercalating proflavine derivative.

Authors:  W Müller; D M Crothers; M J Waring
Journal:  Eur J Biochem       Date:  1973-11-01

7.  Calculation of binding isotherms for heterogenous polymers.

Authors:  D M Crothers
Journal:  Biopolymers       Date:  1968-04       Impact factor: 2.505

8.  Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: evidence for molecular models involving intercalation.

Authors:  M Waring
Journal:  J Mol Biol       Date:  1970-12-14       Impact factor: 5.469

9.  Direct determination of the superhelix density of closed circular DNA by viscometric titration.

Authors:  B M Révet; M Schmir; J Vinograd
Journal:  Nat New Biol       Date:  1971-01-06

10.  The change of the torsion of the DNA helix caused by intercalation. II. Measurement of the relative change of torsion induced by various intercalating drugs.

Authors:  J M Saucier; B Festy; J B Le Pecq
Journal:  Biochimie       Date:  1971       Impact factor: 4.079

View more
  15 in total

1.  A theoretical investigation of the base sequence preferences of monointercalating polymethylene carboxamide derivatives 9-aminoacridine.

Authors:  C Coulombeau; N Gresh
Journal:  Nucleic Acids Res       Date:  1990-02-25       Impact factor: 16.971

2.  Binding of ethidium bromide causes dissociation of the nucleosome core particle.

Authors:  C T McMurray; K E van Holde
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  A theoretical study of anthracene and phenanthrene derivatives acting as A-T specific intercalators.

Authors:  K X Chen; N Gresh; B Pullman
Journal:  Nucleic Acids Res       Date:  1986-11-25       Impact factor: 16.971

4.  Binding of ethidium derivatives to natural DNA: a 300 MHz 1H NMR study.

Authors:  J Feigon; W Leupin; W A Denny; D R Kearns
Journal:  Nucleic Acids Res       Date:  1982-01-22       Impact factor: 16.971

5.  Human topoisomerase I poisoning: docking protoberberines into a structure-based binding site model.

Authors:  Viktor Kettmann; Daniela Kost'álová; Hans-Dieter Höltje
Journal:  J Comput Aided Mol Des       Date:  2005-06-27       Impact factor: 3.686

Review 6.  New hopes from old drugs: revisiting DNA-binding small molecules as anticancer agents.

Authors:  Katerina Gurova
Journal:  Future Oncol       Date:  2009-12       Impact factor: 3.404

7.  Viscometric analysis of the interaction of bisphenanthridinium compounds with closed circular supercoiled and linear DNA.

Authors:  W D Wilson; R A Keel; R L Jones; C W Mosher
Journal:  Nucleic Acids Res       Date:  1982-07-10       Impact factor: 16.971

8.  Is the bithiazole moiety of bleomycin a classical intercalator?

Authors:  J P Hénichart; J L Bernier; N Helbecque; R Houssin
Journal:  Nucleic Acids Res       Date:  1985-09-25       Impact factor: 16.971

9.  Nucleic acid-binding molecules with high affinity and base sequence specificity: intercalating agents covalently linked to oligodeoxynucleotides.

Authors:  U Asseline; M Delarue; G Lancelot; F Toulmé; N T Thuong; T Montenay-Garestier; C Hélène
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

10.  Binding of ethidium and bis(methidium)spermine to Z DNA by intercalation.

Authors:  R H Shafer; S C Brown; A Delbarre; D Wade
Journal:  Nucleic Acids Res       Date:  1984-06-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.